Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. (15th May 2017) - Covell, D. J.
Abstract : Aims: The aim of this study was to test the hypothesis that different conformations of misfolded α‐synuclein (α‐syn) are present in Parkinson's disease (PD) brain. Methods: Using two previously characterized conformations of α‐syn fibrils, we generated new conformation‐selective α‐syn monoclonal antibodies (mAbs). We then interrogated multiple brain regions in a well‐characterized autopsy cohort of PD patients ( n = 49) with these mAbs, Syn7015 and Syn9029. Results: Syn7015 detects Lewy bodies (LBs) and Lewy neurites (LNs) formed by pathological α‐syn in all brain regions tested, and is particularly sensitive to LNs and small Lewy dots, inclusions believed to form early in the disease. Further, we observed colocalization between Syn7015 and an early marker of α‐syn pathology formation, phospho‐Ser129‐α‐syn, and a lack of extensive colocalization with markers of more mature pathology. In comparison, Syn9029 detects Lewy pathology in all regions examined, but indicates significantly fewer LNs than Syn7015. In addition, colocalization of Syn9029 with later markers of α‐syn pathology maturation (ubiquitin and P62) suggests that the pathology detected by Syn9029 is older. Semiquantitative scoring of both LN and LB pathology in nine brain regions further established this trend, with Syn7015 LN scores consistently higher than Syn9029 LN scores. Conclusions: Our data indicate that different conformations of α‐syn pathology are present in PD brain and correspond to different stages of maturity for Lewy pathology. Regional analysis of Syn7015 and Syn9029 immunostaining also provides support for the Braak hypothesis that α‐syn pathology advances through the brain. Abstract : Conformation specific antibodies have been used to demonstrate that α‐synuclein is present in different conformations in Parkinson's disease and that conformation of the protein may alter as inclusions mature. The findings are important as researchers seek to develop therapeutic agents targeting α‐synuclein.